Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bedrocan Cannabis Corp. V.BED

Healthcare Biotechnology


TSXV:BED - Post by User

Bedrocan Cannabis Corp. > back to .75
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(5)
•••
Comment by jackripperIXon Jun 26, 2015 1:49pm
103 Views
Post# 23873008

RE:RE:RE:back to .75

RE:RE:RE:back to .75
cobills wrote:  Oh great we have a new newbie investor who has been on sh for 2 day's.All this clown will do is be a critic.This board is for opinions.Whether you like them or not.


What? I never said i dont like you experts opinion, on contrary, i love reading them because i'm learning a lot and i did mention i was a newbie. Thank you for your contribution sir. 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities